Live Breaking News & Updates on அப்போட் இந்தியா லிமிடெட்

Stay updated with breaking news from அப்போட் இந்தியா லிமிடெட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Abbott India Ltd Q1FY22 PAT rises to Rs. 195.76 crores

Abbott India Ltd Q1FY22 PAT rises to Rs. 195.76 crores
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Abbott India Ltd , Time Zone , Abbott India , அப்போட் இந்தியா லிமிடெட் , நேரம் ஸோந் , அப்போட் இந்தியா ,

Abbott India share price: Buy Abbott India, target price Rs 21,225: Centrum Broking

Abbott India share price: Buy Abbott India, target price Rs 21,225: Centrum Broking
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Abbott India Ltd , India Ltd , Large Cap , அப்போட் இந்தியா லிமிடெட் , இந்தியா லிமிடெட் , பெரியது தொப்பி ,

Top Pharmaceutical Companies in India - Insider Monkey


Top Pharmaceutical Companies in India
In this article we will take a look at the top 15 pharmaceutical companies in India. You can skip our detailed analysis of the pharma industry’s outlook for 2021, and some of the major growth catalysts for pharmaceutical stocks, and go directly to the
Since late 2019, after the world was caught off-guard owing to the COVID-19 pandemic, the pharma industry has taken the center stage as they raced to develop and produce vaccines. Medicines being an essential requirement, the pharmaceuticals industry has always been the vital resource and the safest stock market sector for the public, but with this recent worldwide health crisis, the importance of this industry has become more pronounced than ever.  During the inception of the pandemic, drug makers, including the 15 largest drug companies in the world, were confronting the coronavirus on one hand while on the other hand, they were barging through uncertainty regarding research and dev ....

Andhra Pradesh , United States , United Kingdom , South Africa , Northern Samar , Zydus Cadila , Sandoz Novartis , Samprada Singh , Binnish Chudgar , Ipca Laboratorieslimited , Gracias Saldanha , Aurobindo Pharma , David Toung , Ramabhai Patel , Trinity Laboratories Ltd , Bombay Stock Exchange Healthcare Index , Top Pharmaceutical Companies , Merck Co Inc , Pfizer Inc , Moderna Inc , Cadila Healthcare , York Stock Exchange , Torrent Pharmaceuticals Ltd , Torrent Pharmaceuticals , Drug Administration , World Health Organization ,

Abbott India share price: Buy Abbott India, target price Rs 18497: ICICI Securities


ICICI Securities has buy call on
Abbott India with a target price of Rs 18497. The current market price of Abbott India Ltd. is Rs 15978.35.
Abbott India Ltd., incorporated in the year 1944, is a Large Cap company (having a market cap of Rs 34113.31 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-03-2021, the company reported a Standalone Total Income of Rs 1111.74 Crore, up .12 % from last quarter Total Income of Rs 1110.38 Crore and up 12.37 % from last year same quarter Total Income of Rs 989.33 Crore. Company reported net profit after tax of Rs 152.47 Crore in latest quarter.
The brokerage raises sales and earnings estimates by 1-2% and 0-2% respectively for FY22E-FY23E to reflect higher growth in key brands. It maintains BUY with a revised target price of Rs18,497/share based on 42xFY23E EPS (earlier: Rs18,195/share). Key downside risks are: addition of key drugs in NLEM, product concentration, government intervention, an ....

Abbott India Ltd , Abbott India , India Ltd , Large Cap , Standalone Total Income , Total Income , Abbott India Share Price , Stocks To Buy , Market News , அப்போட் இந்தியா லிமிடெட் , அப்போட் இந்தியா , இந்தியா லிமிடெட் , பெரியது தொப்பி , மொத்தம் வருமானம் , ஸ்டாக்ஸ் க்கு வாங்க , சந்தை செய்தி ,

Bandhan Bank, Godrej Consumer among top large cap stocks sold by MFs in Jan


Bandhan Bank, Godrej Consumer among top large cap stocks sold by MFs in Jan
​ By
IANS
|
Published on
​ Wed, Feb 17 2021 20:48 IST
|
​ 0 Views
Bandhan Bank.. Image Source: IANS News
New Delhi, Feb 17 : As equity and equity-linked mutual fund schemes continue to witness outflow of funds, Bandhan Bank, Godrej Consumer and Abbott India Ltd were among the top stocks to be sold by mutual funds in the month of January.
As per the data from the Association of Mutual Funds in India (AMFI), equity-linked mutual fund schemes saw a net outflow of Rs 9,253.22 crore last month.
The net outflow stood at Rs 10,147.12 crore in December, Rs 12,917.36 crore in November, Rs 2,724.95 crore in October, and Rs 734.40 crore in September. ....

India General , New Delhi , Astec Lifesciences , Association Of Mutual Funds , India Ltd , Power Grid Corporation , Punjab National Bank , Abbott India Ltd , Asset Management Company Ltd , Bajaj Holdings Investment , Payment Services , Bandhan Bank , Hindustan Aeronautics , Steel Authority , Godrej Consumer Products Ltd , Kirloskar Oil Engines , Piramal Enterprises , Godrej Consumer , Mutual Funds , Abbott India , Management Company Ltd , Power Grid Corporation Of India , Adani Ports , Special Economic Zone , Hindustan Zinc , Asian Paints ,